Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Sanders-van Wijk

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
European Journal of Heart Failure|June 28, 2020
Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic reviewMichiel T H M Henkens, Sharon Remmelzwaal, Emma L Robinson, et al.
Nature Medicine|March 30, 2025
Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trialJob J Herrmann, Hans-Peter Brunner-La Rocca, Lisette E H J M Baltussen, et al.
ESC Heart Failure|February 4, 2022
Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registryMichiel T H M Henkens, Jerremy Weerts, Job A J Verdonschot, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
European Journal of Heart Failure|June 28, 2020
Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic reviewMichiel T H M Henkens, Sharon Remmelzwaal, Emma L Robinson, et al.
Nature Medicine|March 30, 2025
Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trialJob J Herrmann, Hans-Peter Brunner-La Rocca, Lisette E H J M Baltussen, et al.
ESC Heart Failure|February 4, 2022
Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registryMichiel T H M Henkens, Jerremy Weerts, Job A J Verdonschot, et al.
Pageof 6